However, the role of ADORA3 in human airway inflammation is not yet fully understood, thus it is still unclear whether agonists or antagonists of ADORA3 would be of any value for the treatment of asthma and COPD (40). This evidence concerns the gene ADORA3 and chronic obstructive pulmonary disease.